Cargando…

Evaluating programmed death‐ligand 1 (PD‐L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study

AIMS: The introduction of immunotherapy for patients with head and neck squamous cell carcinoma (HNSCC) raises the need for harmonisation between different types of antibody and immunohistochemistry platform for evaluating the expression of PD‐L1 by use of the combined positive score (CPS) in this t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cerbelli, Bruna, Girolami, Ilaria, Eccher, Albino, Costarelli, Leopoldo, Taccogna, Silvia, Scialpi, Renzo, Benevolo, Maria, Lucante, Teresa, Luigi Alò, Piero, Stella, Francesca, Gemma Pignataro, Maria, Fadda, Guido, Perrone, Giuseppe, D’Amati, Giulia, Martini, Maurizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299113/ https://www.ncbi.nlm.nih.gov/pubmed/34496080 http://dx.doi.org/10.1111/his.14562

Ejemplares similares

PD-L1 Testing in Gastric Cancer by the Combined Positive Score of the 22C3 PharmDx and SP263 Assay with Clinically Relevant Cut-offs
por: Park, Yujun, et al.
Publicado: (2020)

Intrapatient Tumor Heterogeneity in IHC Interpretation Using PD-L1 IHC 22C3 pharmDx
por: Kalpakoff, Megan, et al.
Publicado: (2021)

An Analytical Comparison of Dako 28-8 PharmDx Assay and an E1L3N Laboratory-Developed Test in the Immunohistochemical Detection of Programmed Death-Ligand 1
por: Cogswell, John, et al.
Publicado: (2016)

Analysis of real-world PD-L1 IHC 28-8 and 22C3 pharmDx assay utilisation, turnaround times and analytical concordance across multiple tumour types
por: Krigsfeld, Gabriel S, et al.
Publicado: (2020)

Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications
por: Vainer, Gilad, et al.
Publicado: (2023)

Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2−, node-positive early breast cancer
por: Crager, Michael, et al.
Publicado: (2022)

Comparison of HercepTest™ mAb pharmDx (Dako Omnis, GE001) with Ventana PATHWAY anti-HER-2/neu (4B5) in breast cancer: correlation with HER2 amplification and HER2 low status
por: Rüschoff, Josef, et al.
Publicado: (2022)

Overexpression in metastatic breast cancer supports Syndecan-1 as a marker of invasiveness and poor prognosis
por: Cerbelli, Bruna, et al.
Publicado: (2022)

The analytical validation of the Oncotype DX Recurrence Score assay
por: Baehner, Frederick L
Publicado: (2016)

Spotlight on the utility of the Oncotype DX(®) breast cancer assay
por: Siow, Zhen Rong, et al.
Publicado: (2018)

Commentary: Impact of Digital Pathology in the Field of Intraoperative Neuropathology: Master the Tool
por: Eccher, Albino, et al.
Publicado: (2020)

Results of Adrenalectomy for Isolated, Metachronous Metastasis of Breast Cancer: A Retrospective Cohort Study
por: Illuminati, Giulio, et al.
Publicado: (2021)

Pathological examination of breast cancer samples before and after neoadjuvant therapy: recommendations from the Italian Group for the Study of Breast Pathology - Italian Society of Pathology (GIPaM-SIAPeC)
por: Fusco, Nicola, et al.
Publicado: (2022)

Concordance between Three PD-L1 Immunohistochemical Assays in Head and Neck Squamous Cell Carcinoma (HNSCC) in a Multicenter Study
por: Guerini Rocco, Elena, et al.
Publicado: (2022)

Commentary: The Digital Fate of Glomeruli in Renal Biopsy
por: Girolami, Ilaria, et al.
Publicado: (2021)

Digital pathology all stars
por: Eccher, Albino, et al.
Publicado: (2022)

Examination of the Biomark assay as an alternative to Oncotype DX for defining chemotherapy benefit
por: Kim, Jinkyoung, et al.
Publicado: (2019)

Atypical cellular neurothekeoma (ACN) of the elderly: case report and brief review of the literature
por: D’Alessandris, Nicoletta, et al.
Publicado: (2020)

Value of Artificial Intelligence in Evaluating Lymph Node Metastases
por: Caldonazzi, Nicolò, et al.
Publicado: (2023)

DecisionDx-GBM Gene Expression Assay for Prognostic Testing in Glioblastoma Multiform
por: Allingham-Hawkins, Diane, et al.
Publicado: (2010)

Evaluation of PhageDX Salmonella Assay for Salmonella Detection in Hydroponic Curly Lettuce
por: de Aquino, Nathanyelle Soraya Martins, et al.
Publicado: (2021)

Analytic validation of NeXT Dx™, a comprehensive genomic profiling assay
por: Saldivar, Juan-Sebastian, et al.
Publicado: (2023)

Digital Slide Assessment for Programmed Death-Ligand 1 Combined Positive Score in Head and Neck Squamous Carcinoma: Focus on Validation and Vision
por: Eccher, Albino, et al.
Publicado: (2021)

Fat pharms.
por: Ma, M
Publicado: (1996)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

PD-L1 Expression in TNBC: A Predictive Biomarker of Response to Neoadjuvant Chemotherapy?
por: Cerbelli, Bruna, et al.
Publicado: (2017)

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsies
por: Knezevic, Dejan, et al.
Publicado: (2013)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience
por: Crolley, Valerie E., et al.
Publicado: (2020)

423. SARS-CoV-2 NGS Assay Powered by Biotia COVID-DX Software
por: Nagy-Szakal, Dorottya, et al.
Publicado: (2020)

Clinical Validation of the Fully Automated NeuMoDx HPV Assay for Cervical Cancer Screening
por: Heideman, Daniëlle A. M., et al.
Publicado: (2022)

Congenital granular cell epulis of newborn: importance of prenatal diagnosis
por: Torresani, Evelin, et al.
Publicado: (2021)

Performance Evaluation of the Beckman Coulter DxN VERIS Hepatitis B Virus (HBV) Assay in Comparison With the Abbott RealTime HBV Assay
por: Park, Joonhong, et al.
Publicado: (2019)

External quality assessment demonstrates that PD‐L1 22C3 and SP263 assays are systematically different
por: Dodson, Andrew, et al.
Publicado: (2019)

Integrated Multiparametric Radiomics and Informatics System for Characterizing Breast Tumor Characteristics with the OncotypeDX Gene Assay
por: Jacobs, Michael A., et al.
Publicado: (2020)

Reflex Detection of Ciprofloxacin Resistance in Neisseria gonorrhoeae by Use of the SpeeDx ResistancePlus GC Assay
por: Lee, Darren Y. J., et al.
Publicado: (2021)

PharmFrag: An Easy and Fast Multiplex Pharmacogenetics Assay to Simultaneously Analyze 9 Genetic Polymorphisms Involved in Response Variability of Anticancer Drugs
por: Bouvet, Régis, et al.
Publicado: (2020)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Innovation in Transplantation: The Digital Era
por: Eccher, Albino, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ho43cfgd0mevoqe2629q3danns